Minimally-invasive cardiac implantable devices for treating mitral valve regurgitation without atriotomy or cardiopulmonary bypass
There’s no risk. Start your trial today to see profiles of Myocor (Acquired) plus 5234 other startups.
Start Free 7 Day Trial Now